Alertness and feeding behaviors in ADHD: Does the hypocretin/orexin system play a role?

Samuele Cortese, Eric Konofal, Michel Lecendreux

Research output: Contribution to journalArticle

Abstract

Increasing evidence has suggested that patients with attention-deficit/hyperactivity disorder (ADHD) may present with a deficit of alertness and sleep disturbances. Recent studies have also pointed out a previously underestimated association between ADHD and abnormal eating behaviors, including binge eating. Since sleep/alertness disturbances and eating disorders may significantly increase the functional impairment of ADHD, gaining insight into their pathophysiology as well as into their treatment is of relevance to provide a better clinical management of patients suffering from ADHD. The hypocretin/orexin system comprises two distinct peptides, located in the hypothalamus, which are involved in several homeostatic functions. In particular, it has been suggested that hypocretin/orexin neurons located in perifornical and dorsomedial hypothalamic nuclei increase arousal, whereas those located in the lateral hypothalamus are primarily implicated in reward processing, stimulating feeding and other reward seeking behaviors. Given the involvement of the hypocretin/orexin system in the control of alertness and reward seeking (including feeding), we hypothesize that hypocretin/orexin neurons located in perifornical and dorsomedial hypothalamic areas are hypoactivated, while those located in the lateral hypothalamus are overactivated in patients with ADHD. If confirmed by further neurophysiological, imaging, and genetics studies, our hypothesis may help us progress in the understanding of the complex pathophysiology of ADHD. This might set the basis for the study of novel molecules, acting on the hypocretin/orexin system, aimed at increasing wakefulness and reducing binge eating and other abnormal reward seeking behaviors in patients with ADHD. We also suggest future studies on the potential therapeutic role of other molecules which have a complex interplay with the hypocretin/orexin system, such as the histamine H1 receptor agonists, the histamine H3 receptor antagonists, and the neuropeptide Y receptor antagonists. All this body of research would provide a tremendous opportunity to improve the quality of life of patients with ADHD by means of pathophysiologically oriented treatment.

Original languageEnglish
Pages (from-to)770-775
Number of pages6
JournalMedical Hypotheses
Volume71
Issue number5
DOIs
Publication statusPublished - Nov 2008

Fingerprint

Feeding Behavior
Attention Deficit Disorder with Hyperactivity
Reward
Lateral Hypothalamic Area
Bulimia
Sleep
Histamine H3 Antagonists
Dorsomedial Hypothalamic Nucleus
Neuropeptide Y Receptors
Histamine Agonists
Neurons
Orexins
Wakefulness
Arousal
Hypothalamus
Therapeutics
Quality of Life
Peptides
Research

Keywords

  • ADHD
  • Alertness
  • Attention-deficit/hyperactivity disorder
  • Eating
  • Feeding
  • Histamine
  • Hypocretin
  • Neuropeptide Y
  • Orexin
  • Sleep

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Alertness and feeding behaviors in ADHD : Does the hypocretin/orexin system play a role? / Cortese, Samuele; Konofal, Eric; Lecendreux, Michel.

In: Medical Hypotheses, Vol. 71, No. 5, 11.2008, p. 770-775.

Research output: Contribution to journalArticle

Cortese, Samuele ; Konofal, Eric ; Lecendreux, Michel. / Alertness and feeding behaviors in ADHD : Does the hypocretin/orexin system play a role?. In: Medical Hypotheses. 2008 ; Vol. 71, No. 5. pp. 770-775.
@article{f72a803857554f798c0f3aa3f69586d9,
title = "Alertness and feeding behaviors in ADHD: Does the hypocretin/orexin system play a role?",
abstract = "Increasing evidence has suggested that patients with attention-deficit/hyperactivity disorder (ADHD) may present with a deficit of alertness and sleep disturbances. Recent studies have also pointed out a previously underestimated association between ADHD and abnormal eating behaviors, including binge eating. Since sleep/alertness disturbances and eating disorders may significantly increase the functional impairment of ADHD, gaining insight into their pathophysiology as well as into their treatment is of relevance to provide a better clinical management of patients suffering from ADHD. The hypocretin/orexin system comprises two distinct peptides, located in the hypothalamus, which are involved in several homeostatic functions. In particular, it has been suggested that hypocretin/orexin neurons located in perifornical and dorsomedial hypothalamic nuclei increase arousal, whereas those located in the lateral hypothalamus are primarily implicated in reward processing, stimulating feeding and other reward seeking behaviors. Given the involvement of the hypocretin/orexin system in the control of alertness and reward seeking (including feeding), we hypothesize that hypocretin/orexin neurons located in perifornical and dorsomedial hypothalamic areas are hypoactivated, while those located in the lateral hypothalamus are overactivated in patients with ADHD. If confirmed by further neurophysiological, imaging, and genetics studies, our hypothesis may help us progress in the understanding of the complex pathophysiology of ADHD. This might set the basis for the study of novel molecules, acting on the hypocretin/orexin system, aimed at increasing wakefulness and reducing binge eating and other abnormal reward seeking behaviors in patients with ADHD. We also suggest future studies on the potential therapeutic role of other molecules which have a complex interplay with the hypocretin/orexin system, such as the histamine H1 receptor agonists, the histamine H3 receptor antagonists, and the neuropeptide Y receptor antagonists. All this body of research would provide a tremendous opportunity to improve the quality of life of patients with ADHD by means of pathophysiologically oriented treatment.",
keywords = "ADHD, Alertness, Attention-deficit/hyperactivity disorder, Eating, Feeding, Histamine, Hypocretin, Neuropeptide Y, Orexin, Sleep",
author = "Samuele Cortese and Eric Konofal and Michel Lecendreux",
year = "2008",
month = "11",
doi = "10.1016/j.mehy.2008.06.017",
language = "English",
volume = "71",
pages = "770--775",
journal = "Medical Hypotheses",
issn = "0306-9877",
publisher = "Churchill Livingstone",
number = "5",

}

TY - JOUR

T1 - Alertness and feeding behaviors in ADHD

T2 - Does the hypocretin/orexin system play a role?

AU - Cortese, Samuele

AU - Konofal, Eric

AU - Lecendreux, Michel

PY - 2008/11

Y1 - 2008/11

N2 - Increasing evidence has suggested that patients with attention-deficit/hyperactivity disorder (ADHD) may present with a deficit of alertness and sleep disturbances. Recent studies have also pointed out a previously underestimated association between ADHD and abnormal eating behaviors, including binge eating. Since sleep/alertness disturbances and eating disorders may significantly increase the functional impairment of ADHD, gaining insight into their pathophysiology as well as into their treatment is of relevance to provide a better clinical management of patients suffering from ADHD. The hypocretin/orexin system comprises two distinct peptides, located in the hypothalamus, which are involved in several homeostatic functions. In particular, it has been suggested that hypocretin/orexin neurons located in perifornical and dorsomedial hypothalamic nuclei increase arousal, whereas those located in the lateral hypothalamus are primarily implicated in reward processing, stimulating feeding and other reward seeking behaviors. Given the involvement of the hypocretin/orexin system in the control of alertness and reward seeking (including feeding), we hypothesize that hypocretin/orexin neurons located in perifornical and dorsomedial hypothalamic areas are hypoactivated, while those located in the lateral hypothalamus are overactivated in patients with ADHD. If confirmed by further neurophysiological, imaging, and genetics studies, our hypothesis may help us progress in the understanding of the complex pathophysiology of ADHD. This might set the basis for the study of novel molecules, acting on the hypocretin/orexin system, aimed at increasing wakefulness and reducing binge eating and other abnormal reward seeking behaviors in patients with ADHD. We also suggest future studies on the potential therapeutic role of other molecules which have a complex interplay with the hypocretin/orexin system, such as the histamine H1 receptor agonists, the histamine H3 receptor antagonists, and the neuropeptide Y receptor antagonists. All this body of research would provide a tremendous opportunity to improve the quality of life of patients with ADHD by means of pathophysiologically oriented treatment.

AB - Increasing evidence has suggested that patients with attention-deficit/hyperactivity disorder (ADHD) may present with a deficit of alertness and sleep disturbances. Recent studies have also pointed out a previously underestimated association between ADHD and abnormal eating behaviors, including binge eating. Since sleep/alertness disturbances and eating disorders may significantly increase the functional impairment of ADHD, gaining insight into their pathophysiology as well as into their treatment is of relevance to provide a better clinical management of patients suffering from ADHD. The hypocretin/orexin system comprises two distinct peptides, located in the hypothalamus, which are involved in several homeostatic functions. In particular, it has been suggested that hypocretin/orexin neurons located in perifornical and dorsomedial hypothalamic nuclei increase arousal, whereas those located in the lateral hypothalamus are primarily implicated in reward processing, stimulating feeding and other reward seeking behaviors. Given the involvement of the hypocretin/orexin system in the control of alertness and reward seeking (including feeding), we hypothesize that hypocretin/orexin neurons located in perifornical and dorsomedial hypothalamic areas are hypoactivated, while those located in the lateral hypothalamus are overactivated in patients with ADHD. If confirmed by further neurophysiological, imaging, and genetics studies, our hypothesis may help us progress in the understanding of the complex pathophysiology of ADHD. This might set the basis for the study of novel molecules, acting on the hypocretin/orexin system, aimed at increasing wakefulness and reducing binge eating and other abnormal reward seeking behaviors in patients with ADHD. We also suggest future studies on the potential therapeutic role of other molecules which have a complex interplay with the hypocretin/orexin system, such as the histamine H1 receptor agonists, the histamine H3 receptor antagonists, and the neuropeptide Y receptor antagonists. All this body of research would provide a tremendous opportunity to improve the quality of life of patients with ADHD by means of pathophysiologically oriented treatment.

KW - ADHD

KW - Alertness

KW - Attention-deficit/hyperactivity disorder

KW - Eating

KW - Feeding

KW - Histamine

KW - Hypocretin

KW - Neuropeptide Y

KW - Orexin

KW - Sleep

UR - http://www.scopus.com/inward/record.url?scp=52949108437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52949108437&partnerID=8YFLogxK

U2 - 10.1016/j.mehy.2008.06.017

DO - 10.1016/j.mehy.2008.06.017

M3 - Article

C2 - 18678446

AN - SCOPUS:52949108437

VL - 71

SP - 770

EP - 775

JO - Medical Hypotheses

JF - Medical Hypotheses

SN - 0306-9877

IS - 5

ER -